|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.950 EUR | -1.68% |
|
-5.60% | -30.42% |
| 06-08 | Intrasense and Guerbet Obtain PMDA Certification In Japan For DUOnco Pancreas AI Software | CI |
| 06-08 | Guerbet and Intrasense secure landmark regulatory approval in Japan |  |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 3 | |||||||
| 14 | |||||||
| 5 | |||||||
| 5 | |||||||
| 2 | |||||||
| - | - | ||||||
| - | 1 | ||||||
| 5 | |||||||
| 3 | |||||||
| 3 | |||||||
| 3 | |||||||
| 3 | |||||||
| 2 | |||||||
| Average | 4 | |||||||
| Weighted average by Cap. | 10 |
- Stock Market
- Stocks
- GBT Stock
- Sector Guerbet
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
